Tag: limb

NSC Invests $300,000 in Next-Generation Solutions for Safer Workplaces

Grants advance research and pilot programs to prevent musculoskeletal disorders WASHINGTON, June 25, 2025 /PRNewswire/ -- The National Safety Council awarded $300,000 to the 2025-2026 Research...

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

SHANGHAI and NANJING, China and SAN FRANCISCO, June 22, 2025 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development,...

Fletcher Zone Maiden Mineral Resource of 2.3Moz

Stage 1 Fletcher Resource almost doubles the current Beta Hunt Resource PERTH, Western Australia, June 23, 2025 /CNW/ - Westgold Resources Limited (ASX: WGX) (TSX: WGX)...

Big Tech Execs Play Soldier—What a Joke

You can't make this stuff up: Silicon Valley execs are now donning Army fatigues. Meta's CTO Andrew "Boz" Bosworth, and a few other tech...

EASTERN PLATINUM LIMITED ANNOUNCES ACCEPTANCE OF DIRECTOR RESIGNATION

VANCOUVER, BC, June 19, 2025 /CNW/ - Eastern Platinum Limited ("Eastplats" or the "Company") announces the Board of Directors of the Company (the "Board") has...

Critical Limb Ischemia Treatment Market to Reach USD 10.02 Billion by 2032, Owing to Rising Demand for Minimally Invasive Vascular Therapies | Coherent Market...

Burlingame, CA, June 18, 2025 (GLOBE NEWSWIRE) -- The Coherent Market Insights reveals that the Critical Limb Ischemia Treatment Market is estimated to be valued at USD 5.55 Bn in 2025 and is expected to reach USD 10.02 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. The critical limb ischemia treatment market is projected to experience significant growth during the forecast period. Key factors driving this expansion include the increasing global geriatric population and the rising prevalence of peripheral artery disease, both of which are contributing to a growing demand for effective treatment options.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsLimb

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress

MUSSO E80 Muse Sees Strong U.S. Sales Following European Breakout and MUSE Design Award Win

Tag: limb

NSC Invests $300,000 in Next-Generation Solutions for Safer Workplaces

Transaction in Own Shares

Transaction in Own Shares

Transaction in Own Shares

IASO Bio presents promising efficacy of Equecabtagene Autoleucel in patients with Multiple Sclerosis in IIT study at the 11th Congress of the European Academy...

Fletcher Zone Maiden Mineral Resource of 2.3Moz

Big Tech Execs Play Soldier—What a Joke

Transaction in Own Shares

Transaction in Own Shares

EASTERN PLATINUM LIMITED ANNOUNCES ACCEPTANCE OF DIRECTOR RESIGNATION

Critical Limb Ischemia Treatment Market to Reach USD 10.02 Billion by 2032, Owing to Rising Demand for Minimally Invasive Vascular Therapies | Coherent Market...

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us